4th September 2019 – Global Foot
and Mouth Disease (FMD) Vaccine Market is anticipated to reach USD 3.0
billion by 2025. Foot-and-Mouth disease, also termed as “Hoof-and-Mouth
Disease” implies an infectious and contagious viral disease that affects
cloven-hoofed animals, involving wild and domestic bovids. The after-effects of
foot and mouth disease include high fever that lasts for two to six days. The
symptoms include blisters on the feet and inside the mouth. Foot and Mouth
Disease (FMD) Vaccine has significant economic impact.
The factors that propel the growth of
the market include changing lifestyle coupled with change in food preference,
increasing awareness among people, and increased acceptance of oil-based
vaccines due to their developed effectiveness. On the other hand, there are
factors that may hamper the growth of the market such as less immunity, high cost,
instability at room temperature (3-8°C). Foot and Mouth Disease Vaccine Market
is anticipated to grow at a significant CAGR of 8.1% in the upcoming period as
the scope, product types, and its applications are increasing across the globe.
Get
a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/foot-mouth-disease-fmd-vaccine-market/request-sample
Foot and Mouth Disease (FMD) Vaccine
Industry may be explored by product type, application, and geography. The
market may be explored by product type as Conventional vaccines, and Emergency
vaccines. The “Conventional vaccines” section dominated the FMD Vaccine Market
in 2016 and is anticipated to maintain its dominance by 2025 owing to an
increasing penetration of oil-based vaccines due to their higher efficacy and
long-term effectiveness.
Foot and Mouth Disease (FMD) Vaccine
Market may be explored by application as Sheep and goats, Cattle, and Pigs. The
“Cattle” section dominated the Foot and Mouth Disease Vaccine industry in 2016
and is anticipated to maintain its dominance by 2025 owing to improved demand
for livestock products. Asia-Pacific accounted for the major share of the Foot
and Mouth Disease (FMD) Vaccine Market Size in 2016 and will continue to lead
in the forthcoming period. The factors that could attribute to the growth
include growing R&D investment. Asia-Pacific is followed by North America.
Some of the key players that fuel the
growth of the Foot and Mouth Disease (FMD) Vaccine industry comprise Ceva,
SEPPIC, Bayer HealthCare, Inovio Pharmaceuticals, and Plumbline Life Sciences,
Merck, BiogénesisBagó, Indian Immunologicals, Brilliant Bio Pharma, Boehringer
Ingelheim. The leading companies are taking up partnerships, mergers and
acquisitions, and joint ventures in order to increase the inorganic growth of
the industry.
For More Details, Visit @ http://www.millioninsights.com
No comments:
Post a Comment